> 资讯
Synchronoss Technologies to Present at Upcoming Investor Conferences
GlobeNewswire 2025-01-08 09:23:49 资讯BRIDGEWATER, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, today announced that Jeff Miller, President and CEO, and Louis Ferraro, CFO, will participate at two upcoming investor conferences.
- ICR Conference on January 13, 2025. The presentation will begin at 11:00 AM ET and the webcast link will be available on the Synchronoss Investor Relations website here, or directly here.
- Needham Growth Conference on January 16, 2025. To register for one-on-one meetings with management, please contact a Needham sales representative.
About Synchronoss
Synchronoss Technologies (Nasdaq: SNCR), a global leader in personal Cloud solutions, empowers service providers to establish secure and meaningful connections with their subscribers. Our SaaS Cloud platform simplifies onboarding processes and fosters subscriber engagement, resulting in enhanced revenue streams, reduced expenses, and faster time-to-market. Millions of subscribers trust Synchronoss to safeguard their most cherished memories and important digital content. Explore how our Cloud-focused solutions redefine the way you connect with your digital world at www.synchronoss.com.
Media Relations Contact:
Domenick Cilea
Springboard
dcilea@springboardpr.com
Investor Relations Contact:
Ryan Gardella
ICR for Synchronoss
SNCRIR@icrinc.com
相关推荐
- 便捷与保障并重:OntrailVisa助台湾旅客轻松踏上菲律宾旅程
- 捷信持续助力筑牢金融安全防线,防范非法金融活动
- Synchronoss Technologies to Present at Upcoming Investor Conferences
- Ambiq and ThinkAR Disrupt the AR Glasses Industry with the AiLens
- Caseware Announces Acquisition of LeaseJava
- Founder Group Secures Letter of Award Valued at US$4.5 Million for Floating Solar Farm Project in Ma
- Bitget Introduces Bank Deposits with ZEN Integration, Enabling Access for Eleven Fiat Currencies
- Hummingbird Bioscience Licenses Novel Antibodies to Immunome
- Hummingbird Bioscience Licenses Novel Antibodies to Immunome
- Hummingbird Bioscience Licenses Novel Antibodies to Immunome
- 搜索
-
- 01-08便捷与保障并重:OntrailVisa助台湾旅客轻松踏上菲律宾旅程
- 01-08捷信持续助力筑牢金融安全防线,防范非法金融活动
- 01-08Synchronoss Technologies to Present at Upcoming Investor Conferences
- 01-08Ambiq and ThinkAR Disrupt the AR Glasses Industry with the AiLens
- 01-08Caseware Announces Acquisition of LeaseJava
- 01-08Founder Group Secures Letter of Award Valued at US$4.5 Million for Floating Solar Farm Project in Ma
- 01-08Bitget Introduces Bank Deposits with ZEN Integration, Enabling Access for Eleven Fiat Currencies
- 01-08Hummingbird Bioscience Licenses Novel Antibodies to Immunome
- 01-08Hummingbird Bioscience Licenses Novel Antibodies to Immunome
- 01-08Hummingbird Bioscience Licenses Novel Antibodies to Immunome
- 标签列表